Expression of developing neural transcription factors in lung carcinoid tumors

Pathology International

Volumn 64, Issue 8, 2014, Pages 365-374

  Endo, Tetsuya ^a,b   Yazawa, Takuya ^a,d   Shishido Hara, Yukiko ^a   Fujiwara, Masachika ^a   Shimoyamada, Hiroaki ^a   Ishii, Jun ^a   Sato, Hanako ^c   Tachibana, Keisei ^a   Takei, Hidefumi ^a   Kondo, Haruhiko ^a   Goya, Tomoyuki ^a   Endo, Shunsuke ^b   Kamma, Hiroshi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ASCL1; BRN2; Carcinoid tumor; High grade neuroendocrine tumor; Large cell neuroendocrine carcinoma; Lung; MEN1; Small cell carcinoma; TTF1

Indexed keywords

CHROMOGRANIN A; KI 67 ANTIGEN; NERVE CELL ADHESION MOLECULE L1; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRN2; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOID; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH GRADE NEUROENDOCRINE TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CANCER; LUNG CARCINOID TUMOR; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL CARCINOMA; SMOKING; CANCER GRADING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906266510     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12183     Document Type: Article

References (36)

1. Travis WB, Nicholson S, Hirsch FR etal. Small cell carcinoma. In: Travis WB, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press, 2004; 31-34.
2. Brambilla E, Pugatch B, Geisinger K etal. Large cell carcinoma. In: Travis WB, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press, 2004; 45-50.
3. Beasley MB, Thunnissen FB, Hasleton PS etal. Carcinoid tumour. In: Travis WB, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press, 2004; 59-62.
4. Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab Invest 2006; 86: 425-444.
5. Debelenko LV, Brambilla E, Agarwal SK etal. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genetics 1997; 6: 2285-2290.
6. Debelenko LV, Swaiwell JI, Kelley MJ etal. MENI gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chr Cancer 2000; 28: 58-65.
7. Barbareschi M, Girlando S, Mauri FA etal. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 1992; 166: 343-350.
8. Cagle PT, El-Naggar AK, Xu HJ, Hu SX, Benedict WF. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Am J Pathol 1997; 150: 393-400.
9. Yuan J, Knorr J, Altmannsberger M etal. Expression of p16 and lack of pRB in primary small cell lung cancer. J Pathol 1999; 189: 358-362.
10. Kitamura H, Yazawa T, Okudela K, Shimoyamada H, Sato H. Molecular and genetic pathogenesis of lung cancer: Differences between small-cell and non-small-cell carcinomas. Open Pathol J 2008; 2: 106-114.
11. Kitamura H, Yazawa T, Sato H, Okudela K, Shimoyamada H. Small cell lung cancer: Significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology. Endocr Pathol 2009; 20: 101-107.
12. Nakamura N, Miyagi E, Murata S, Kawaoi A, Katoh R. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol 2002; 15: 1058-1067.
13. Folpe AL, Gown AM, Lamps LW etal. Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999; 12: 5-8.
14. Sakaeda M, Sato H, Ishii J etal. Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small cell lung cancer. Lab Invest 2013; 93: 408-421.
15. Lazzaro D, Price M, De Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the fetal brain. Development 1991; 113: 1093-1104.
16. Nakai S, Kawano H, Yudate M etal. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev 1995; 9: 3109-3121.
17. Schonemann MD, Ryan AK, McEvilly RJ etal. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev 1995; 9: 3122-3135.
18. Sturm N, Rossi G, Lantuejoul S etal. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002; 33: 175-182.
19. Du EZ, Goldstraw P, Zacharias J etal. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004; 35: 825-831.
20. Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001; 32: 1087-1093.
21. Ball DW, Azzoli CG, Baylin SB etal. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 1993; 90: 5648-5652.
22. Jiang SX, Kameya T, Asamura H etal. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 2004; 17: 222-229.
23. Kashiwagi K, Ishii J, Sakaeda M etal. Differences of molecular expression mechanisms among neural cell adhesion molecule1, synaptophysin, and chromogranin A in lung cancer cells. Pathol Int 2012; 62: 232-245.
24. Ishii J, Sato H, Sakaeda M etal. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1, and neuroendocrine marker molecules and cell growth in small cell lung cancer. Pathol Int 2013; 63: 158-168.
25. Travis WD. Advances in neuroendocrine tumors. Ann Oncol Suppl 2010; 7: vii65-71.
26. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids. Review of 124 cases. J Thorac Cardiovasc Surg 1985; 89: 8-17.
27. Guru SC, Cabtree JS, Brown KD etal. Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome 1999; 10: 592-596.
28. Asamura H, Kameya T, Matsuno Y etal. Neuroendocrine neoplasms of the lung: A prognostic spectrum. J Clin Oncol 2006; 24: 70-76.
29. Swarts DRA, Ramaekers FCS, Speel EJM. Molecular and cellular biology of neuroendocrine lung tumors: Evidence for seaprate biological entities. Biochim Biophys Acta 2012; 1826: 255-271.
30. Gouyer V, Gazzeri S, Bolon I, Drevet C, Brambilla C, Brambilla E. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. Am J Respir Cell Mol Biol 1998; 18: 188-196.
31. Peifer M, Fernandez-Cuesta L, Sos ML etal. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012; 44: 1104-1110.
32. Nagashio R, Sato Y, Matsumoto T etal. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas. Pathol Int 2010; 60: 71-77.
33. Sun L, Sakurai S, Sano T, Hironaka M, Kawashima O, Nakajima T. High-grade neuroendocrine carcinoma of the lung: Comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Pathol Int 2009; 59: 522-529.
34. Oshiro Y, Kusumoto M, Matsuno Y etal. CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. Am J Roentgenol 2004; 182: 87-91.
35. Jones MH, Virtanen C, Honjoh D etal. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004; 363: 775-781.
36. D'Adda T, Pelosi G, Lagrasta C etal. Genetic alterations in combined neuroendocrine neoplasms of the lung. Mod Pathol 2008; 21: 414-422.